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Abstract
Objective: The objective of this study was to determine whether the detection of Aggregatibacter
actinomycetemcomitans (Aa) correlates with the clinical and immunoinflammatory profile of Localized Aggressive
Periodontitis (LAP), as determined by by 16S rRNA gene-based microarray.
Subjects and Methods: Subgingival plaque samples from the deepest diseased site of 30 LAP patients [PD ≥ 5 mm,
BoP and bone loss] were analyzed by 16S rRNA gene-based microarrays. Gingival crevicular fluid (GCF) samples
were analyzed for 14 cyto/chemokines. Peripheral blood was obtained and stimulated in vitro with P.gingivalis and
E.coli to evaluate inflammatory response profiles. Plasma lipopolysaccharide (LPS) levels were also measured.
Results: Aa was detected in 56% of LAP patients and was shown to be an indicator for different bacterial community
structures (p<0.01). Elevated levels of pro-inflammatory cyto/chemokines were detected in LPS-stimulated blood
samples in both Aa-detected and Aa-non-detected groups (p>0.05). Clinical parameters and serum LPS levels were
similar between groups. However, Aa-non-detected GCF contained higher concentration of IL-8 than Aa-detected
sites (p<0.05). TNFα and IL1β were elevated upon E.coli LPS stimulation of peripheral blood cells derived from
patients with Aa-detected sites.
Conclusions: Our findings demonstrate that the detection of Aa in LAP affected sites, did not correlate with clinical
severity of the disease at the time of sampling in this cross-sectional study, although it did associate with lower local
levels of IL-8, a different subgingival bacterial profile and elevated LPS-induced levels of TNFα and IL1β.
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Introduction
Aggregatibacter actinomycetemcomitans (Aa) is a Gram-
negative bacterium that colonizes the oral cavity of one third or
more of the population aged up to 18 years [1]. It has been
highly implicated as the causative agent of aggressive
periodontitis (AgP), a group of less frequent, often severe,
rapidly progressive forms of periodontitis, with a more localized
presentation of the disease (LAP) [2-4]. LAP is also
characterized by an early age of onset, tendency for familial
involvement, and bone loss affecting specifically molar and
incisor teeth, [5]. Importantly, recent papers have pointed out
the importance Aa, a particularly highly leukotoxic clone (JP2),
in the initiation of attachment loss in young individuals [4,6,7].
Our group has recently demonstrated a hyper-inflammatory
trait in response to bacterial endotoxin in an LAP cohort of
PLOS ONE | www.plosone.org 1 December 2013 | Volume 8 | Issue 12 | e85066
African-Americans, which results in the over-expression of pro-
inflammatory cyto/chemokines [8]. We also observed an
exacerbated local inflammatory response, along with high
systemic levels of bacterial lipopolysaccharides (LPS) [9].
Additionally, we have reported Aa to be highly associated with
LAP in this cohort [10]. However, we could not detect Aa in
every patient with LAP in our cohort, which is also consistent to
previously reported literature [11]. Little is known regarding the
impact of Aa’s presence on LAP disease presentation (clinical
parameters and bacterial colonization) or the accompanying
inflammatory response (regulation and local presentation).
Thus, the objective of this study was to evaluate our LAP
cohort in relation to the presence of Aa and determine whether
the detection of this species in LAP affected sites correlate with
clinical presentation of disease, local cyto/chemokines, plasma




This study was conducted in full conformity with the
principles set forth in The Belmont Report: Ethical Principles
and Guidelines for the Protection of Human Subjects of
Research, as drafted by the US National Commission for the
Protection of Human Subjects of Biomedical and Behavioral
Research (April 18, 1979) and codified in 45 CFR Part 46
and/or the ICH E6; 62 Federal Regulations 25691 (1997). This
study was approved by the University of Florida Institutional
Review Board.
Subject demographics
Subjects were selected from a cohort recruited from Leon
County Health Department, Tallahassee, Florida, from
February 2007 to August 2010. This study is part of a larger
clinical trial (Clinical trial registration: #NCT01330719 at
www.clinicaltrials.gov). A comprehensive microbiological profile
as well as local and LPS-induced inflammatory response from
initial subjects enrolled in this study has been reported in our
previous publications [8-10]. Both historical data and newly
generated data were part of the present analysis. Specifically,
all subjects enrolled in the clinical trial that had their baseline
microbiological analysis completed were included in the
present report[10], and new data on local and systemic
inflammatory markers for some of these patients were run to
fulfill the present investigation (see flowchart, Figure 1). Eight
of the participants had siblings within the cohort, who happen
to be part of the random pool of participants on which
microbiological analysis had been completed. All subjects and
parents were informed about the study protocol and signed an
informed consent previously approved by the University of
Florida Institutional Review Board. Inclusion criteria: subjects
aged 5-21 years old, African-American, diagnosed with
localized aggressive periodontitis, defined by presence of at
least 2 sites, on first molar and/or incisor, with pocket depth
>4mm with bleeding on probing, presence of at least 2mm
clinical attachment loss and radiographic bone loss [5,12].
Exclusion criteria: subjects diagnosed with any systemic
diseases or conditions that could influence the progression
and/or clinical characteristics of periodontal disease (e.g.,
diabetes or blood disorders); taken antibiotics within the last 3
months or any medications that could influence the
characteristics of the disease (e.g., phenytoin, cyclosporine);
have received periodontal treatment within the previous 6
months; smokers; and pregnant/lactating women.
Clinical measurements
The following periodontal clinical parameters were taken by
one calibrated examiner at the baseline visit (prior to
treatment): Pocket Depth (PD), Bleeding on probing (BoP);
Gingival margin position (GM), Clinical attachment level (CAL);
Plaque Index (PI). All measurements were performed using a
UNC-15 periodontal probe at six sites per tooth and recorded
using a computer software program (Florida Probe, Gainesville,
FL, USA). Periapical and interproximal radiographs were taken
on all patients at the baseline visit for diagnosis purposes only.
Gingival Crevicular Fluid (GCF) sampling
Following clinical examination, and on the same day,
samples were collected from the most severe diseased site
(PD ≥ 5mm with BoP and CAL≥2 mm and radiographic bone
loss). Sites for GCF collection were isolated with cotton rolls,
gently air-dried and supragingival plaque removed. A collection
strip (PerioPaper GCF collection strips, Oraflow Inc, Plainview,
NY) was inserted in the sites 1-2 mm into the sulcus for ~10
sec, as described previously [9]. Volume of GCF was
measured using aPeriotron®8000, (Oraflow, Inc.). GCF
samples were frozen at -70°C until analysis of soluble
mediators was performed.
Collection of bacterial sub-gingival biofilm
Subgingival plaque samples were collected from the same
diseased site where GCF collection was made, as described
above, also prior to treatment. The area of collection was
isolated with cotton rolls and supragingival plaque was carefully
removed. A sterile endodontic paper point was used for the
Figure 1.  Schematic flowchart of study design.  
doi: 10.1371/journal.pone.0085066.g001
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collection, placed in an eppendorf tube and stored at -70°C
until processed.
Microbial microarray analysis
DNA was isolated from plaque samples as previously
described [10]. After purification, DNA concentration and
quality was determined using the Nanodrop (ND-1000
Spectrophotometer, Nanodrop Technologies INC, Wilmington,
DE, USA). Samples were analyzed at the Forsyth Institute
using the Human Oral Microbe Identification Microarrays
(HOMIM) as previously described [10,13]. Briefly, 16S rRNA
genes were PCR amplified from DNA extracts using 16S rRNA
universal forward and reverse primers and labeled via
incorporation of Cy3-dCTP in a second nested PCR. HOMIM
uses16S rRNA-based, reverse-capture oligonucleotide probes
(typically 18 to 20 bases), which are printed on aldehyde-
coated glass slides and probed with labeled PCR products
described above which are hybridized in duplicate. The
microarray slides are scanned using an Axon 4000B scanner
and crude data is extracted using GenePix Pro software
(Molecular Devices, Sunnyvale, CA). Microbial profiles were
generated from image files of scanned arrays using a HOMIM
online analysis tool (http://bioinformatics.forsyth.org/homim/).
Detection of a particular taxon was determined by presence of
a fluorescent spot for that unique probe. A mean intensity for
each taxon was calculated from hybridization spots of the same
probe and signals were normalized by comparing individual
signal intensities to the average of signals from universal
probes and calculated as described previously [13]. Any
original signal that was less than two times the background
value was reset to 1 and was assigned to the signal level 0.
Signals greater than 1 were categorized into scores from 1 to
5, corresponding to ranked signal levels. Presence of Aa was
determined if a site showed value of 1 or above. Absence of Aa
was determined if a site showed a value of ‘0’
In vitro LPS stimulation
Peripheral blood was collected in heparinized tubes, diluted
1:4 in RPMI1640 (Invitrogen, Carlsbad, CA, USA) and
stimulated with 1 μg/mL of ultrapure E.coli (Ec) LPS or
P.gingivalis (Pg) LPS (InvivoGen, San Diego, CA, USA), or left
untreated, for 24hrs [8]. After which the resulting supernatants
were collected and stored at -70°C until analysis of soluble
mediators was performed.
Analysis of soluble mediators
Multiplex assays (Milliplex® 14-plex cytochemokine detection
kits, Millipore, St. Charles, MO, USA) were used to detect and
quantify 14 cyto/chemokines (Eotaxin, TNFα, IFNγ, IL1β, IL2,
IL6, IL7, IL8, IL10, IL12p40, MCP-1, G-CSF, GM-CSF and
MIP1α) in the crevicular fluid and LPS-stimulated culture
supernatants according to the manufacture’s protocol. Data
was acquired on the Luminex®200™ (Millipore, St. Charles,
MO) and analyzed with Milliplex Software (Viagene Tech,
Carlisle, MA, USA), a standard curve and 5-parameter
logistics. Data is reported as pg/ml. GCF data is normalization
to total protein content: normalized pg/ml = [pg/ml x protein
content corrective ratio], where corrective ratio = [lowest protein
concentration/protein concentration of sample of interest].
Plasma LPS levels
Peripheral blood was collected in heparinized tubes, after
which . plasma was separated from red blood cells by
centrifugation (~300 x g for 15 min) and stored at -70°C. LPS
levels were detected and quantified by using a chromogenic
assay (Endpoint Chromogenic LAL Assay, Lonza, Basel,
Switzerland). Endotoxin units/ml were calculated using a
standard curve and best fit linear trend line, as previously
described [9].
Statistical analysis
Means were calculated and t-test was performed to compare
patients presenting Aa-detected sites versus patients
presenting Aa-non-detected sites for clinical and
immunoinflammatory parameters. Mann-Whitney Rank Sum
Test was applied when data was not normally distributed.
ANOVA analyses were used for comparisons within groups for
LPS stimulation using different ligands. This study was
powered at >80% to detect a 10% difference between the two
groups in cyto/chemokine values [values based on previous
publication data [8,9]] and a PD difference in affected sites of at
least 1 mm with standard deviation of 0.9 mm. SigmaPlot
version 11.0 software (Systat Software Inc, Chicago, IL) was
used for statistical analysis, considering a 5% significance
level. We considered cyto/chemokines to be independent
variables and thus, no statistical corrections were done here
[14]. Canonical correspondence analysis (CCA), nonmetric
multidimensional scaling (NMDS), and ANOVA tests were used
on HOMIM hybridization scores to test for significant effects of
environmental variables on microbial community structures
within sites with or without the detection of Aa, using the Vegan
package for the R statistical programming environment [15].
For generating CCA plots, Aa was excluded from the list of
taxa. To account for the multiple hypotheses, we adjusted p-
value using Benjamini/Hochberg correction [16].
Results
Clinical and microbiologic characterization
HOMIM resulted in 189 probes identifying at least 137
different bacterial taxa in diseased sites of LAP (for a more
comprehensive microbial data description, including healthy
controls, see [10]). Among these, two taxa of Aa were
identified: Aa_ot531_AA84 and Aa_ot531_P02. Sites
presenting any signal for Aa (value 1 or greater) were
considered Aa-detected (n=17) and those that did not present
any signal for Aa (value 0) were considered Aa-non-detected
(n=13). HOMIM analysis’ mean relative signal intensity of Aa in
the Aa-detectedsites was 3.81±1.02, in a 0 to 5 signal scale.
Interestingly, clinical parameters and demographics were
similar between individuals with Aa-detected or Aa-non-
detected sites, as determined by HOMIM (Table 1).
In NMDS and CCA plots (Figure 2), samples with similar
community composition cluster close together, while samples
Localized Aggressive Periodontitis and Aa Presence
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with different community compositions are farther apart on the
plots; preserving the rank order of the original similarities [17].
Both NMDS and CCA analysis suggest that the detection of Aa
was associated with specific bacterial community structures (of
all variables tested, only the presence of Aa was statistically
significant, permutation test under the reduced model with
p<0.01). PD was not statistically significant relative to Aa
detection (p=0.24) and therefore was not included in CCA. The
left side of the CCA ordination plot is predominantly occupied
by diseased sites containing Aa, whereas on the right side are
predominantly diseased sites in which Aa was not detected.
We observed that Granulicatella elegans (p=0.01) and
Prevotella loeschii (p=0.02) were frequently found in samples
co-existing when Aa was present. In contrast, Porphyromonas
gingivalis (p=0.02) and Parvimonas micra (p=0.03) were more
likely to be found in Aa-non-detected communities. These
significances disappear when corrected for multiple
comparisons.
Local inflammatory profile and systemic LPS levels
As previously published, high levels of several inflammatory
mediators were detected in the GCF of diseased sites of LAP
participants [9]. Eotaxin, G-CSF and IL7 were not detected in
high enough levels and thus were not included in the
association analysis. In general, no differences in the GCF
mediator profiles were detected between Aa-detected and Aa-
non-detected sites (Figure 3). However, IL8 was found at
higher concentrations in Aa-non-detected sites than those
observed in Aa-detected sites (p=0.011). After controlling
values for GCF volume at each diseased site of collection, the
same trends were observed, and p-values slightly decreased,
but did not reach statistical significance. Systemic LPS levels
were similar in Aa-non-detected and Aa-detected groups
(Mean values 0.61±0.15 and 0.68±0.36, respectively; p=0.773).
LPS-induced hyper-responsive phenotype
The LPS responsiveness of individuals with Aa-non-detected
and Aa-detected groups was compared. There was no
significant differences between the levels of cyto/chemokines in
unstimulated cultures of Aa-detected and Aa-non-detected
individuals. Pg and Ec LPS-stimulation of whole blood cell
preparation resulted in elevated levels of multiple pro-
inflammatory cyto/chemokines when compared with
unstimulated cultures (p<0.05). There were few significant
differences in the levels of cyto/chemokines induced when
comparing cohorts which had Aa-detected or Aa-non-detected
sites. Specifically, Ec LPS stimulation elicited more robust
levels of TNFα and IL1β from peripheral blood of individuals
with Aa-detectedsites than those with Aa-non-detected sites
(p<0.05) (Figure 4). In addition, GM-CSF was more highly
induced by Pg LPS-stimulation in individuals with Aa-non-
detected sites, compared to those with Aa-detected sites,
although the difference did not reach significance (Figure 4).
Discussion
It has been previously suggested that an individual organism
can play a strong role in community restructuring, and in turn
impact the ecological processes of the system [18,19]. This
change in community structure can also have an effect on local
immune responses and thus the course of periodontal disease
progression. Among periodontal pathogens, Aa has received
particular attention and has been regarded as a key factor in
the etiology of LAP. This view was based primarily on classic
association studies linking Aa to disease and correlating
treatment outcomes to its levels after therapy [20-25].
However, in a systematic review [11], it was shown that the
presence or absence of Aa could not discriminate between
subjects with aggressive periodontal disease from those with
chronic periodontitis.
The present study focused on the presence of Aa as a
determinant factor in some aspects of disease presentation.
We observed a lack of association between Aa detection, as
measured by HOMIM, and severity of clinical signs of the
disease (i.e. pocket depth, clinical attachment levels at time of
sampling). This is not unexpected, considering that the criteria
for diagnosis of LAP used in this study are very strict for clinical
signs of disease, although it is impossible to determine the
disease state of the sampled sites, even before treatment is
rendered. However, if we were to include healthy individuals or
even healthy sites (i.e. PD≤3mm and no bop), the presence of
Aa could indeed be more correlated with the diseased clinical
parameters [4,6,7,10,26]. It should be noted that the HOMIM
assay has a sensitivity of about 0.1% and an overall limit of
detection about 104 cells (Colombo, 2009). Consequently, it is
possible that Aa at levels below the level of detection could still
be present. Nevertheless, Aa-detected sites presented very
high signal levels for (mean relative signal intensity was 3.81),
which makes the two populations very distinct for Aa detection
using HOMIM. Interestingly, at this detection level, the
Table 1. Clinical and demographic parameters for Aa+(positive) and Aa-(negative) groups.
 Age M/F %PD>4mm %BoP %Plaque Mean PD sites/all(mm) Mean CAL(mm) PD site (mm)
Aa+ 13.19±3.94 8m/9f 12.76±7.81 19.41±10.05 43.64±25.88 5.02±0.71 /2.27±0.40 3.94±1.53 5.94±1.19
Aa- 15.85±2.67 6m/7f 15.69±11.60 32.84±49.08 45.92±26.85 4.89±0.70/ 2.45±0.44 3.29±1.43 6.61±1.55
P value 0.371* 0.891† 0.416* 0.834† 0.986† 0.608*/0.258* 0.243† 0.220†
Values are given by Means ± Standard deviation. M=male; F=female; Mean PD sites= Mean pocket depth of sites with PD>4mm; Mean PD all= mean PD of all sites;
CAL=clinical attachment level of affected sites; BoP=bleeding on probing; PD site = Pocket depth from site sampled for microbiological analysis. *t-test; †Mann-Whitney
Rank Sum Test.
doi: 10.1371/journal.pone.0085066.t001
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presence or absence of Aa was associated with a difference in
the composition of the microbial community as a whole.
We also evaluated the correlation between the detection of
Aa and local inflammatory mediators as a measure of active
disease. Interestingly, a higher expression of IL-8 in GCF was
Figure 2.  Effect of Aa and microbial community composition, as measured by HOMIM hybridization scores.  The following
variables were chosen as descriptors of the subgingival biofilm community and were calculated for each sample: pocket depth (PD),
and presence of Aa. This last term was chosen to determine if Aa alone reflects shifts in community composition. A. Non-metric
multidimensional scaling analysis (NMDS) and B. Canonical correspondence analysis (CCA) ordination diagrams of microbial
communities. Red circles indicate samples where Aa was detected by HOMIM, and black circles indicate samples where there was
no Aa detected by HOMIM analysis. Aa was critical for determining bacterial community structures (p<0.01).
doi: 10.1371/journal.pone.0085066.g002
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detected in Aa-non-detected sites as compared to Aa-detected
sites. IL-8 is involved in the recruitment of PMNs and is highly
expressed in the junctional epithelium adjacent under the
conditions of health whereby disease has been shown to
modulate these levels both positively and negatively. Many
organisms, including P.gingivalis, have virulence factors which
affect IL8 stability within the GCF. Our data indicate that the
non-detection of Aa results in a different microbial community
than when it is detected at levels above 104, thus it is possible
that the absence/minimal presence of Aa, i.e. Aa-non-detected
sites promotes an environment for an organism that possess
these virulence factors. As demonstrated in our results,
P.gingivalis may be frequently detected when Aa is not, where
IL-8 levels were lower. Although P.gingivalis have been
associated with periodontal inflammatory response, its potential
to induce this response may shift according to the environment,
specific virulent factors, and association with other species of
the biofilm[27]. For instance, specific structures on P.gingivalis
LPS may up-regulate or down-regulate levels of pro-
inflammatory markers, including IL-8[28]. In addition, the
presence of other bacterial species [29], as well as different
peptides [30,31] may also reduce this organism’s pro-
inflammatory abilities. On the other hand, it is possible that Aa
has a direct effect on the suppression of IL8 from the junctional
epithelium. However, the differences in IL8 expression in the
GCF did not correlate with differences in clinical parameters.
Figure 3.  Inflammatory mediator profile in the GCF, in both groups.  Cytochemokines values are reported as normalized
pg/mL. Box-plots show the mean (horizontal line), inter-quartile range (box), 5th -95th percentiles (vertical lines). *Statistically
significant (p=0.01), t-test.
doi: 10.1371/journal.pone.0085066.g003
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Both Aa-detected and Aa-non-detected cohorts had already
advanced clinical signs of LAP, thus IL8 levels may be more
indicative of active vs. inactive disease than severity of
disease, which would also suggest that the presence and/or
absence of Aa may also be a correlate of disease activity,
although data presented here are insufficient to support this
hypothesis. Longitudinal studies of the disease need to be
conducted to asses this hypothesis.
Elevated local inflammation can sometimes result in the
dissemination of bacteria and their products systemically.
Interestingly, no differences in the levels of plasma LPS was
observed between Aa-detected and Aa-non-detected cohorts.
This was not unexpected considering that other than IL8, which
Figure 4.  Systemic LPS-induced cyto/chemokine values in both groups.  Values are reported as normalized log pg/mL. Box-
plots show the mean (horizontal line), inter-quartile range (box), 5th -95th percentiles (vertical lines). *Indicates statistically significant
differences between groups (Aa+ and Aa-) by t-test (p<0.05). #Indicates statistically significant differences within groups regarding
TLR stimulation by One-way ANOVA (p<0.05).
doi: 10.1371/journal.pone.0085066.g004
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does not directly contribute to epithelial ulceration, there were
no significant differences in the levels of cyto/chemokines
within the GCF of the Aa-detected and Aa-non-detected
cohorts.
We have previously published that LAP individuals present
with a hyper-inflammatory phenotype whereby they respond in
a more robust manner to stimuli [8]. Here we demonstrate that
overall whether an individual is colonized with Aa or not does
not correlate with their level of LPS-induced responsive
potential, with one exception. As a group, individuals with
diseased sites that have Aa detected, respond more robustly to
Ec LPS-stimulation as measured by IL1β and TNFα. E.coli LPS
is mainly a TLR4 agonist, as is Aa LPS [32] [33] and this is why
it was chosen for evaluation in the present study. Thus, one
could hypothesize that in Aa carriers the potential for hyper-
secretion of TNFα and IL1β could result in more robust tissue
damage and disease progression. However, we did not
observe elevated levels of TNFα nor IL1β in the GCF of Aa
detected sites, nor was the snapshot of disease severity
different in those individuals with Aa-detected or Aa-non-
detected sites. The direct relationship between Aa presence,
GCF markers and host inflammatory response to LPS cannot
be resolved in this cross-sectional study but could be
determined in future studies that test the likelihood that these
cytokine elevations could be found prior to disease or during
disease progression at the local site.
In summary, the present study demonstrates that, in this
population, similar clinical parameters of disease were
observed regardless of whether Aa was detected or remained
undetected by HOMIM in diseased sites. This study is cross-
sectional and thus, it only represents a snapshot of the disease
state at one point in time. However, our findings indicate
potential differences in the microbial community profile
associated (G.elegans and P.loeschii) or not associated
(P.gingivalis and P.micra) with this species as well as effects
on the local inflammation (IL8 in GCF). Interestingly, individuals
with detectable levels of Aa also present with a TLR4 (Ec LPS)
induced TNFα and IL1β hyper-responsiveness. Further
longitudinal studies are necessary to evaluate whether these
differences could impact disease progression and treatment
responses.
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